Anzeige
Mehr »
Login
Mittwoch, 29.05.2024 Börsentäglich über 12.000 News von 688 internationalen Medien
Künstliche Intelligenz lässt die Nachfrage explodieren - so profitieren Anleger
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A1XCF2 | ISIN: US09062W2044 | Ticker-Symbol: BJX1
Düsseldorf
29.05.24
12:31 Uhr
20,000 Euro
+0,300
+1,52 %
1-Jahres-Chart
BIOLIFE SOLUTIONS INC Chart 1 Jahr
5-Tage-Chart
BIOLIFE SOLUTIONS INC 5-Tage-Chart
RealtimeGeldBriefZeit
20,00020,20016:26
19,90020,20016:24

Aktuelle News zur BIOLIFE SOLUTIONS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
10.05.BIOLIFE SOLUTIONS INC - 10-Q, Quarterly Report3
10.05.BioLife Solutions Inc reports results for the quarter ended in March - Earnings Summary3
09.05.BioLife Solutions GAAP EPS of -$0.22, revenue of $31.7M2
09.05.BioLife Solutions, Inc.: BioLife Solutions Reports First Quarter 2024 Financial Results103Cell Processing revenue increased 10% sequentially to $16.2 million GAAP gross margin of 38% and net loss of $10.2 million Non-GAAP adjusted gross margin expands from 40% to 53% and adjusted EBITDA...
► Artikel lesen
18.04.BIOLIFE SOLUTIONS INC - 8-K, Current Report2
01.03.Earnings call: BioLife Solutions reports Q4 revenue decline, optimistic outlook3
29.02.BioLife Solutions GAAP EPS of -$0.30 beats by $0.04, revenue of $32.73M misses by $0.15M4
29.02.BioLife Solutions, Inc.: BioLife Solutions Reports Fourth Quarter and Full Year 2023 Financial Results161Fourth quarter Cell Processing revenue up 11% sequentially to $14.8 million, and positive adjusted EBITDA of $700,000 Expects 2024 revenue of $95.5 - $100.0 million excluding freezer business and...
► Artikel lesen
08.01.BioLife Solutions says prelim Q4 revenue down 26%6
08.01.BioLife Solutions reports preliminary Q4 and full-year results2
08.01.BIOLIFE SOLUTIONS INC - 8-K, Current Report1
08.01.BioLife Solutions, Inc.: BioLife Solutions Announces Preliminary Fourth Quarter and Full Year 2023 Unaudited Revenue147Fourth quarter Cell Processing revenue increased 11% sequentially to $14.8 million BOTHELL, Wash., Jan. 8, 2024 /PRNewswire/ -- BioLife Solutions, Inc. (NASDAQ: BLFS) ("BioLife" or the "Company")...
► Artikel lesen
09.11.23BioLife Solutions, Inc.: BioLife Solutions Reports Third Quarter 2023 Financial Results159Conference call begins at 4:30 p.m. Eastern time today BOTHELL, Wash., Nov. 9, 2023 /PRNewswire/ -- BioLife Solutions, Inc. (Nasdaq: BLFS) ("BioLife" or the "Company"), a leading supplier of biopreservation...
► Artikel lesen
08.08.23BioLife Solutions, Inc.: BioLife Solutions Reports Second Quarter 2023 Financial Results, Updates Full Year 2023 Guidance and Provides Pro Forma First Half 2023 Financial Profile Excluding Freezer Business167Committed to Divesting Stirling Ultracold and Custom Biogenic Systems by End of 2023 Conference call begins at 4:30 p.m. Eastern time today BOTHELL, Wash., Aug. 8, 2023 /PRNewswire/ -- BioLife Solutions...
► Artikel lesen
14 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1